ResMed Inc. Announces Results for the Third Quarter of Fiscal Year 2022

08:05pm, Thursday, 28'th Apr 2022 GlobeNewswire Inc.
Note: A webcast of ResMed’s conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com
ResMed (RMD) delivered earnings and revenue surprises of -8.33% and 4.86%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?
SAN DIEGO, April 27, 2022 (GLOBE NEWSWIRE) -- ResMed (NYSE: RMD, ASX: RMD) today announced Brett Sandercock, chief financial officer, will present virtually at the Macquarie Australia Conference on

Medical Products Stocks' Earnings on Apr 28: TMO, BIO & More

02:52pm, Wednesday, 27'th Apr 2022 Zacks Investment Research
Medical Products companies' results are likely to reflect a rebound in the base business. Let's see how TMO, BIO, LH and RMD fare this time.
Medical Products companies' results are likely to reflect a rebound in the base business. Let's see how TMO, BIO, LH and RMD fare this time.

Should iShares Morningstar MidCap Growth ETF (IMCG) Be on Your Investing Radar?

10:20am, Wednesday, 27'th Apr 2022 Zacks Investment Research
Style Box ETF report for IMCG

This Tiny Medical Device Will Make Billions of Dollars

12:30pm, Wednesday, 20'th Apr 2022 The Motley Fool
Inspire Medical Systems is radically transforming how we treat sleep apnea.
What should investors do as the global economy swirls? Goldman Sachs says go for stable stocks, like Johnson & Johnson, Domino's Pizza and Alphabet.

2 Top Healthcare Stocks to Buy for the Long Haul

02:15pm, Saturday, 09'th Apr 2022 The Motley Fool
Two stocks that could inflation-proof and recession-proof your portfolio.

2 Top Healthcare Stocks to Buy for the Long Haul

10:15am, Saturday, 09'th Apr 2022
Two stocks that could inflation-proof and recession-proof your portfolio.

What 5 Analyst Ratings Have To Say About ResMed

05:09pm, Wednesday, 06'th Apr 2022 Benzinga
ResMed (NYSE:RMD) has observed the following analyst ratings within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total Ratings 0 3 1 1 0 Last 30D 0 1 0 0

Benzinga's Top Ratings Upgrades, Downgrades For April 6, 2022

02:16pm, Wednesday, 06'th Apr 2022 Benzinga
Upgrades According to Morgan Stanley, the prior rating for Royalty Pharma PLC (NASDAQ:RPRX) was changed from Equal-Weight to Overweight. In the fourth quarter, Royalty Pharma showed an EPS of $0.80, c

How Much Are These Companies Worth?

01:48pm, Tuesday, 29'th Mar 2022 The Motley Fool
This week, Motley Fool analyst Yasser El-Shimy makes his impressive Market Cap Game Show debut.

Markets Fall Amid Rising Oil Prices

08:09pm, Wednesday, 23'rd Mar 2022 Benzinga
U.S. indices finished lower Wednesday as investors continue to weigh the Federal Reserve tapering outlook, inflation concerns and the Russia-Ukraine war. Oil prices have also gained, which has pressur

Catherine Faddis reveals her top health technology stock

02:44pm, Wednesday, 23'rd Mar 2022 Invezz
Looming recession and the Ukraine war; there’s sufficient at present that could scare investors out of the stock market. Still, Grace Capital’s Catherine Faddis remains bullish on U.S. equities. F
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE